At the Indian Institute of Integrative Oncology (IIIO), we continuously evaluate emerging precision therapies that enhance the body's natural ability to fight cancer. Cellular Biotherapy is a personalized cellular immunotherapy that utilizes the patient's own immune system to recognize, target, and destroy cancer cells. Unlike chemotherapy, which directly attacks rapidly dividing cells, Cellular Biotherapy works by strengthening and activating specialized immune cells that naturally protect the body against disease.
Cellular Biotherapy is a personalized treatment designed to improve the body's immune response against cancer.
Depending on the patient's condition, treatment may utilize Dendritic Cells, Natural Killer (NK) Cells, T Lymphocytes (T Cells), B Lymphocytes (B Cells), Macrophages, Cytokines and other immune-signaling molecules. Each treatment is individualized based on clinical evaluation, laboratory findings and cellular testing.
A patient's blood sample is collected and analyzed in a specialized cellular immunology laboratory. Selected immune cells may be isolated, activated, expanded or educated under controlled laboratory conditions before being administered intravenously. Once inside the body, these immune cells work together to recognize abnormal cancer cells, coordinate the immune response and support the body's natural ability to eliminate cancer.
Dendritic Cells: The 'teachers' of the immune system that present cancer proteins to T cells.
NK Cells: The first responders that directly destroy abnormal cancer cells.
T Cells: Precision attack cells that specifically recognize and kill cancer cells while forming immune memory.
B Cells: Produce antibodies that help identify abnormal cells.
Macrophages: Remove damaged cells and help coordinate immune responses.
Cytokines: Natural messenger proteins that allow immune cells to communicate and work together.
Solid Tumors: Breast, Lung, Colorectal, Ovarian, Cervical, Prostate, Pancreatic, Liver, Kidney, Stomach, Head & Neck cancers, Brain Tumors, Melanoma, Sarcomas and other solid malignancies.
Hematological (Liquid) Malignancies: Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPNs).
Given as a controlled intravenous infusion under medical supervision. Patients are monitored throughout treatment.
Usually mild and temporary: fever, fatigue, chills, headache and flu-like symptoms.
May be combined with Gene Silencing Therapy, Hyperthermia, Mistletoe Therapy, High-Dose IV Vitamin C, Nutritional & Metabolic Support and Biofrequency Modulation. Every patient receives a customized treatment protocol.
Cellular Biotherapy is a personalized cellular immunotherapy and should only be administered under qualified medical supervision. It is not a substitute for standard oncological care but may be used as part of an integrative oncology program when clinically appropriate.